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Abstract
Background: Serogroup A Neisseria meningitidis (NmA) was the cause of the 2011 meningitis epidemics in Chad. This
bacterium, often carried asymptomatically, is considered to be an “accidental pathogen”; however, the transition from
carriage to disease phenotype remains poorly understood. This study examined the role genetic diversity might play in
this transition by comparing genomes from geographically and temporally matched invasive and carried NmA isolates.
Results: All 23 NmA isolates belonged to the ST-5 clonal complex (cc5). Ribosomal MLST comparison with other
publically available NmA:cc5 showed that isolates were closely related, although those from Chad formed two distinct
branches and did not cluster with other NmA, based on their MLST profile, geographical and temporal location. Whole
genome MLST (wgMLST) comparison identified 242 variable genes among all Chadian isolates and clustered them into
three distinct phylogenetic groups (Clusters 1, 2, and 3): no systematic clustering by disease or carriage source was
observed. There was a significant difference (p = 0.0070) between the mean age of the individuals from which isolates
from Cluster 1 and Cluster 2 were obtained, irrespective of whether the person was a case or a carrier.
Conclusions: Whole genome sequencing provided high-resolution characterization of the genetic diversity of
these closely related NmA isolates. The invasive meningococcal isolates obtained during the epidemic were not
homogeneous; rather, a variety of closely related but distinct clones were circulating in the human population
with some clones preferentially colonizing specific age groups, reflecting a potential age-related niche adaptation.
Systematic genetic differences were not identified between carriage and disease isolates consistent with invasive
meningococcal disease being a multi-factorial event resulting from changes in host-pathogen interactions along with
the bacterium.
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Background
Neisseria meningitidis (Nm) is a Gram-negative bacterium,
which is frequently carried asymptomatically in the human
nasopharynx. It is considered to be an “accidental patho-
gen”: a normally commensal organism that occasionally
invades the bloodstream causing septicemia and/or menin-
gitis. The factors that determine whether a person infected
with Nm becomes a carrier or a case remain poorly under-
stood. Meningococcal genetic and antigenic diversity are
likely to be important and whole genome comparative ana-
lysis of carriage and disease isolates provides one means of
investigating this. Different approaches have been used to
compare carried and invasive isolates. Early studies com-
pared the proportions of clonal complexes (cc), defined by
Multi Locus Sequence Typing (MLST), among serogroups
and identified hyper-virulent lineages that were overrepre-
sented in invasive isolates and less common in carriage
samples [1]. More recent studies have used whole genome
technology to compare a broad range of disease and car-
riage isolates. These studies have, for example, identified a
prophage present in some disease-associated isolates but
not limited to them [2–4]. Another recent study compared
carried and invasive serogroup Y Nm (NmY) from the UK
and identified a disease-associated clone [5]; however,
there is still much uncertainty over what determines the
carried or invasive state, especially during epidemics.
For over 100 years, the Sahelian and sub-Sahelian
regions of Africa, the African meningitis belt, have
experienced large epidemics of meningococcal disease
[6–13]. Serogroup A N. meningitidis (NmA) was the most
common cause in this region before the introduction of
the TT-PsA conjugate vaccine (MenAfriVac®), which
started in 2010 and will have been deployed in all 26
countries of the meningitis belt by the end of 2016, with
235 million doses administered at the time of writing.
Since vaccine implementation, other previously less com-
mon groups including W (NmW), C (NmC), X (NmX),
and Y (NmY) have been more frequently associated with
meningococcal disease in this region [14].
The southern part of the Republic of Chad lies in the
African meningitis belt and has been subject to recurrent
meningitis outbreaks since the early 1900s [15]. Since 2005,
NmW and NmA have alternated as the major epidemic
strains in small-scale outbreaks [16]. A large epidemic was
recorded in Chad in 2011: seventeen districts reached the
epidemic threshold of 10 per 100,000 per week and a total
of 5960 suspect cases and 270 deaths were reported. Cere-
brospinal fluid samples (CSFs) were obtained from only
3.8% of the cases for laboratory confirmation, but NmA
was the pathogen identified most commonly by culture
and sero-agglutination methods [14]. Vaccination with
MenAfriVac® of all subjects aged 1–29 years old was under-
taken in the capital N’Djamena and in the surrounding area
in 2012 with a dramatic impact on the epidemic, which
continued in the rest of the country [15]. Vaccination of all
previously unvaccinated areas the following year ended the
epidemic and few cases of meningitis have been recorded
since [17]. The MenAfriCar consortium, established in
2009 to study the carriage of Nm before and after the
introduction of MenAfriVac® in the African meningitis
belt, undertook three carriage surveys in the Mandelia
district of Chad, two before and one after the vaccination
campaign [15, 18]. Carriage of NmA was low (<1%) prior
to vaccination but fell to almost zero following vaccine
implementation [15].
Isolates from serogroup A carriers and from patients
with serogroup A invasive disease were retained, providing
an opportunity to compare the genomic characteristics of
carried and invasive isolates obtained during the same
NmA African epidemic. Here we describe the high-
resolution provided by whole genome sequence (WGS)
analysis and demonstrate how this can identify differences
among closely related isolates. No systematic clustering by
carried or invasive phenotype was observed, but three
distinct clusters were identified circulating during the
2011 Chadian epidemic, two of them preferentially iso-
lated from different age groups.
Results
Genome assembly statistics
High-quality draft genomes [19] were obtained for
each isolate (Additional file 1: Table S1). In summary:
the average number of contigs was 154 (range 113 to
243), the average N50 was 43378 (range 28,533 to
52,853); and the average length of the assembled
genome was 2164341 (range 2,155,465 to 2,174,025).
The average number of genes with allele designations,
based on the 1605 Neisseria core genes list [19], was
1568 (97.7%) ranging from 1539 (95.9%) to 1577
(98.3%) loci.
MLST analysis
The 23 isolates all had NmA-associated capsule syn-
thesis genes in region A of the capsule polysacchar-
ide region of the genome [20], as expected, and
belonged to cc5. Three different sequence types (ST)
were found (Table 1), with their Multi-Locus Sequence
Typing (MLST) profiles varying at up to two loci from the
central Sequence Type, ST-5. The majority of isolates (21/
23, 91%) were ST-7 and one isolate was ST-9021. Both
STs had a single allelic difference at the pgm locus from
ST-5. One invasive isolate lacked the gdh gene and
therefore could not be assigned an ST. Comparison of the
contig lacking gdh from this isolate with another isolate
where gdh was present identified the deletion of six
contiguous genes all involved in glucose metabolism,
NEIS1325, NEIS1326, NEIS1328 to NEIS1331 (Additional
file 1: Figure S1).
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rMLST analysis
Higher resolution relationships were obtained through
the comparisons of the 53 ribosomal MLST (rMLST)
loci, which identified six new rSTs: rST-8263; rST-8296;
rST-8303; rST-8311; rST-8323; and rST-8335. The NmA
genomes from Chad exhibited allelic variation in 0 to 5
rMLST loci in pairwise comparisons, with an average of
1.4 loci different. Phylogenetic comparison with other
NmA:cc5 isolates, available through PubMLST.org/neis-
seria [21] (Additional file 1: Table S2), was performed in-
cluding isolates from: a global collection of Nm isolates (n
= 12) [1]; the African meningitis belt (n = 99) [22]; and
other publically available isolates (n = 30) [23, 24]. The
Neighbor-Joining Tree generated showed that most of the
Chadian 2011 NmA (21/23, 91%) formed a distinct branch
(bootstrap value of 66); however, two isolates were found to
cluster separately with a bootstrap value of a 100 (Fig. 1).
Isolates most closely related to the 21 Chadian NmA iso-
lates were from South Africa, Niger, Bangladesh, USA and
Burkina Faso, between 2001 and 2010 and exhibited several
rSTs (rST-7, rST-8428 and rST-2859).
Whole genome MLST (wgMLST) clusters isolates into 3
groups
Allelic comparison with the 2070 genes annotated in the
reference genome (WUE2594) identified 1542 (74.5%)
identical genes among all isolates, 1347 (65.1%) of which
possessed the same allele as WUE2594. A total of 196
(9.5%) genes were identical in the Chad isolates but dif-
ferent from the reference. Sixty-six (3.2%) genes present
in WUE2594 were absent in the Chadian isolates, while
242 (11.7%) were present in all but variable among the
23 NmA isolates from Chad. A total of 221 (10.7%) of
these loci had incomplete sequences, as a consequence
of incomplete assembly and were not included in pairwise
comparisons. Neighbor-Net analysis using a distance matrix
based on 1849 (89.3%) genes (excluding the 221 incomplete
loci) resolved three distinct clusters: Cluster 1, comprising
8 isolates; Cluster 2, 13 isolates; and, Cluster 3, 2 isolates
(Table 2 and Fig. 2a).
Differences among clusters
As cluster 3 comprised only two invasive isolates from
the same geographical location it was not included in
further statistical analysis. A significant difference in the
mean age of the individuals from whom the NmA were
isolated was observed between Clusters 1 and 2, with
Cluster 1 exhibiting a mean age of 7.2 years and Cluster
2 a mean age of 19.5 years, p = 0.007. No significant
difference between the clusters was found for the
gender or residence of individuals from whom the
meningococci were isolated. Cluster-specific allelic
differences were identified in nine loci for Cluster 1 and
10 loci for Cluster 2. These allelic differences included
non-synonymous mutations (NSMs) in seven genes. In
Cluster 1, four of the NSMs led to changes in the chemical
properties of the encoded amino acids (e.g. polar to non-
polar; acidic to basic) and similarly, in Cluster 2 with six
NSMs. In both clusters most of these genes were anno-
tated as encoding components of metabolic pathways,
however, this included enzymes, genes associated with
antibiotic resistance, toxicity, and genetic information
processing (Tables 3 and 4).
Within cluster comparisons identified four genes
that included alleles distinct to the 4 carried isolates
from Cluster 1 (Table 5); however, one of these genes,
NMAA_0123, was found to be identical to that found
in the two invasive isolates in Cluster 3. All of the
other alleles were specific to the carried sub-cluster.
Whole genome Single Nucleotide Polymorphism (wgSNP)
analysis of non-coding regions
WgSNP comparison of the 23 NmA genomes from Chad
and the WUE2594 reference genome identified 1942 SNPs
using assembled fasta sequences as input files, with 1924
SNPs identified when raw fastq files were used. Neighbor
Net trees (Fig. 2b and Additional file 1: Figure S4) gener-
ated from the SNP matrix had a similar topology to those
generated by wgMLST analysis (Fig. 2a).
Using the annotations from the finished genome,
WUE2594, enabled coding-regions, which had been in-
cluded in wgMLST analysis, to be distinguished from
non-coding regions, as well as other regions not found in
the reference genome. There were 182 SNPs (assembled
fasta files) and 181 SNPs (original fastq files) identified in
non-coding regions: the majority of them 109 (fasta) and
112 (fastq) discriminated between the reference genome
and the 23 Chadian NmA; 26 SNPs were specific to Cluster
3; 6 SNPs were specific to Cluster 2 and 16 were specific to
Cluster 1 by both methods. Within those 16 SNPs, only 3
were specific to the whole Cluster 1; a total of nine SNPs
grouped six isolates (PubMLST ID: 34992, 34994, 35007,
Table 1 Summary of MLST profiles
Number of isolates abcZ adk aroE fumC gdh pdhC pgm ST (MLST) Clonal complex (MLST)
21 1 1 2 1 3 2 19 7 ST-5 complex/subgroup III
1 1 1 2 1 3 2 599 9021 ST-5 complex/subgroup III
1 1 1 2 1 - 2 19 ND ST-5 complex/subgroup III
ND: Not Determined
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35008, 35009 and 35013), three SNPs were specific to two
isolates (PubMLST ID: 34991 and 35003) and one SNP was
specific to the four carried isolates (PubMLST ID: 35007,
35008, 35009 and 35013). The other SNPs were unique,
with 13 specific to PubMLST ID: 35007 by both methods
(Additional file 2: Table S4). The SNP specific to the four
carried isolates sub-cluster was mapped to a non-coding re-
gion between NEIS1544 and NEIS1545; an alignment of
that region from all isolates of Cluster 1 allowed the identi-
fication of a nucleotide change from a G to an A, 132 base
pairs upstream of the start codon of NEIS1545.
Discussion
In the absence of comprehensive vaccines, meningococcal
meningitis epidemics remain a serious threat to public
health in the African meningitis belt and elsewhere.
Fig. 1 rMLST Neighbor-Joining Tree of cc5 NmA. The relationship from the concatenated nucleotide sequences of the ribosomal genes between
the NmA isolates from Chad (n = 23) and other publically available cc5 NmA genomes from the PubMLST database is represented in this tree. The
label on each node indicates: the PubMLST ID number, the country, the date and the rST for each isolate represented. A total of 141 other cc5
NmA isolates were found in PubMLST but only one representative of each unique strain (defined as isolates sharing the same alleles at all 53 ribosomal
locus) was included in the tree alongside all the Chadian NmA from the 2011 meningitis epidemic; the full list of publically available cc5 NmA isolates is
shown in Additional file 1: Table S2. The seven-locus MLST profiles of the isolates are indicated by different colored boxes. The position of the reference
genome used in this study (WUE 2594) is represented by a black star
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Understanding the transition from the carried to the inva-
sive phenotype will contribute to improved preventive
measures in both epidemic and non-epidemic periods.
The simultaneous collection of carried and invasive iso-
lates during the 2011 epidemic in Chad enabled the com-
parison of closely related isolates obtained in the same
temporal and geographic sampling frame. Such genomic
comparisons rely on the availability of comprehensive col-
lections of isolates, which are difficult to obtain and access
from countries of the African meningitis belt. For ex-
ample, isolate storage requires a −80 °C freezer with a reli-
able electricity supply. While all of the Chadian isolates
were appropriately stored at −80 °C at the National Refer-
ence Laboratory of N’Djamena, the recovery rate was very
low, perhaps a consequence of delays in the samples
reaching the laboratory and/or difficulties in maintaining
storage temperatures. The invasive isolates were mainly
sourced from different areas around the capital N’Dja-
mena, whilst the carried isolates were all obtained in the
district of Mandelia, situated about 65 km away from
N’Djamena (Additional file 1: Figure S2). The carriage
study involved an age-stratified randomly selected
proportion of the population of the study area and so were
likely to be representative of those circulating in the com-
munity [18], whilst only a small proportion of disease
cases were investigated microbiologically [14]; neverthe-
less, these samples offer comparisons of meningococci
from disease and carriage in the same region at the same
time.
All of the NmA isolates belonged to the hyper-invasive,
pandemic, ST-5 clonal complex (cc5), with rMLST analysis
placing the Chadian epidemic NmA in the context of 141
other publically available NmA:cc5 isolates (Additional file
1: Table S2), dating from 1963 to 2011 and from five conti-
nents allowing a global representation of NmA:cc5. This
confirmed the close genetic relatedness of members of this
complex [25], but the clustering within cc5 was not entirely
congruent with time and place. For example, the Chadian
isolates occupied two different branches: one including the
majority of isolates (n = 21), comprised of 4 different rSTs;
the other comprising the two remaining isolates with
two different rSTs (Fig. 1). These isolates did not
cluster with other meningococci from the African
meningitis belt; however, a global distribution of cc5
Table 2 Epidemiological data associated with the host of the isolates and bacterial clusters
ID Epidemiological data of the host Bacterial characteristica
PubMLST Phenotype Sex Age (year/month) ST rST Genomic clusters
34990 Disease F 6 ST-7 rST-8263 2
34991 Disease M 10 ST-7 rST-8296 1
34992 Disease M 11 ST-7 rST-8303 1
34994 Disease F 0/5 ST-9021 rST-8296 1
34995 Disease M - ST-7 rST-8311 3
34996 Disease M 15 ST-7 rST-8323 3
34997 Disease M 15 ST-7 rST-8335 2
34998 Disease - - ST-7 rST-8335 2
34999 Disease - - ST-7 rST-8335 2
35000 Disease M 11 ST-7 rST-8335 2
35001 Disease M 18 ST-7 rST-8335 2
35002 Disease M 16 ND rST-8335 2
35003 Disease - - ST-7 rST-8296 1
35004 Carriage M 36 ST-7 rST-8263 2
35005 Carriage M 14 ST-7 rST-8335 2
35006 Carriage F 28 ST-7 rST-8263 2
35007 Carriage F 4 ST-7 rST-8296 1
35008 Carriage M 12 ST-7 rST-8296 1
35009 Carriage M 7 ST-7 rST-8296 1
35010 Carriage M 36 ST-7 rST-8263 2
35011 Carriage F 22 ST-7 rST-8335 2
35012 Carriage F 13 ST-7 rST-8263 2
35013 Carriage F 6 ST-7 rST-8296 1
aAll the isolates had the following strain designation: A: P1. 20,9: F3-1: ST: cc5; the variable STs are indicated in the table
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sub-variants spanning several years was apparent with
isolates from Bangladesh, USA, and South Africa
clustering with Chadian meningococci and isolates
from Niger or Burkina.
Chadian isolates were present on branches of the phyl-
ogeny that were distinct from those which included the
ST-7 and ST-2859 NmA isolates from Ghana and Burkina
Faso, which have also been analyzed at the whole genome
a
b
Fig. 2 wgMLST and wgSNP Neighbor Net Tree. The genomic relationship based on wgMLST (2a) and wgSNP (2b) between the Chad NmA isolates is
depicted in relation to the reference genome WUE2594. Three clusters are observed and labeled on both trees. The invasive isolates are depicted in
red and the carried ones in yellow. The rSTs contained in each cluster are also indicated as well as age and region of the patient/healthy volunteer are
indicated when available, ND corresponds to the absence of any epidemiological information for the specific isolate (2a). The tree were produced
based on a comparison in terms of n = 2070 loci defined in the reference genome (2a) and the 1942 SNPs identified (2b)
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level [22], highlighting the need for the additional reso-
lution obtained by rMLST in epidemiological studies [24].
The two isolates from Cluster 3 were more distantly re-
lated, as were the two Chinese isolates, indicating that this
relatively small sample contained much of the diversity
seen in publically available isolates from different loca-
tions. The previous study [22] noted potentially significant
changes between ST-7 and ST-2859 NmA isolates at: (i)
the pgl locus, involved in glycosylation mechanisms; (ii) pi-
lus regulation associated genes; and (iii) the maf3 locus. In
the Chad isolates, which were mostly ST-7, Cluster 1 and
Cluster 2 shared the same alleles as the Ghanaian ST-7
isolates at the pglD, pglC and pglB locus: Cluster 3 had a
different allele which may represent the acquisition of
Deoxyribonucleic acid (DNA) from another source by
homologous genetic transfer. The pglH locus was located
at the beginning or the end of a contig in the majority of
the draft genomes obtained and consequently its diversity
could not be assessed in this analysis. The pilus genes were
also variable in the Chad isolates but their variation did
not correlate with the Clusters identified. On the other
hand, all the Chadian isolates shared the same maf3 alleles
as the Ghanaian ST-7 isolates. Whole genome comparison
of the NmA:cc5 isolates clearly showed that the Chadian
isolates were distinct at multiple loci from the Burkina
Faso and Ghanaian isolates (Additional file 1: Figure S3);
additional whole genome comparisons are required, how-
ever, to elucidate further differences between these two
isolate collections.
This study is the first description of a meningococcus
lacking the gdh gene, encoding glucose-6-phosphate 1-
dehydrogenase, making it impossible to define its se-
quence type by seven-locus MLST and reiterating the
usefulness of whole genome analysis. The deleted region
also included loci encoding a 6-phosphogluconolactonase, a
glucokinase, and pgi1 (a glycose-6-phophate isomerase)
which are involved in glucose metabolism. Glucose being
an essential source of energy for Nm in blood and CSF
Table 3 Genes with alleles specific to Cluster 1 isolates
Locus Functional category Number of mutation Number of non-synonymous
mutation
NEIS2150 (alx/TerC) Integral membrane protein (tellurite resistance protein) 1 (bp 676) 1 (A→ S)a
NMAA_0255 Insertion element IS1016 transposase 1 (bp 28) 1 (T→ A)a
NEIS0947 (trpG) Amino acid metabolism (phenylalanine, tyrosine and
tryptophan biosynthesis)
1 (bp 414) 0
NMAA_0798 Hypothetical protein 1 (bp 400) 1 (E→ K)a
NEIS1071 Hypothetical protein 1 (bp 461) 1 (Y→ C)
NEIS1383 (aroD) Amino acid metabolism (phenylalanine, tyrosine and
tryptophan biosynthesis)
1 (bp 418) 1 (V→M)
NEIS1605 Enzyme (TatD DNase family) 1 (bp 186) 0
NEIS1742 (murG) Glycan metabolism/Vancomycin resistance 1 (bp 632) 1 (A→ V)
NEIS2135 Nicotinate and nicotinamide metabolism 1 insertion (bp 155) 15 stop codona
aChange in the chemistry properties of the AA side chains
Table 4 Genes with alleles specific to cluster 2 isolates
Locus Functional category Number of mutation Number of non-synonymous
mutation
NEIS0370 (carA) Metabolism (pyrimidine and alanine, aspartate and glutamate) 1 (bp 1057) 1 (T→ A)a
NEIS0422 (metK) Metabolism (cysteine and methionine metabolism) 1 (bp 726) 0
NEIS0529 Metal ions transport (zinc/manganese) 1 (bp 363) 0
NEIS1091 (cysl) Metabolism (sulfite reductase) 1 (bp 1021) 1 (P→ T)a
NEIS1237 (cmk) Metabolism (pyrimidine) 1 (bp 611) 1 (I→ T)a
NEIS1379 (dnaZX) Metabolism/DNA processing 1 (bp 1774) 1 (G→ S)a
NEIS1460 Putative metabolism (Glucose-6-Phosphate 1-Dehydrogenase_bact motif) 1 (bp 402) 0
NEIS1741 (murC) Metabolism (D-glutamine/D-Glutamate, peptidoglycan biosynthesis) 1 (bp 397) 1 (A→ S)a
NEIS1804 putative role in toxicity (associated with Maf Genomic islands
MGI-1 scheme pubmlst)
1 (bp 868) 1 (F→ V)
NEIS0132 (rplC) Genetic information processing (ribosomal protein) 1 (bp 22) 1 (C→ R)a
aChange in the chemistry properties of the AA side chains
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[26], such an invasive isolate would be at a disadvantage
during an infection. This deletion probably occurred during
sub-cultivation and is unlikely to be of biological relevance.
Whole genome gene-by-gene analysis identified three dif-
ferent NmA clusters circulating during the epidemic in
Chad. Isolates were very similar, with 74.5% of the genes
identical in all genomes and 242 (11.6%) genes confirmed as
variable. No clustering by disease phenotype was evident,
with Clusters 1 and 2 containing both disease and carried
isolates in similar proportions, indicating that the invasive
and carried isolates circulating during the epidemic were
part of the same bacterial population. This was consistent
with previous genomic comparisons among more diverse
carried and disease isolates, which found no distinct mono-
phyletic groups by gene content [4] or SNP analysis [22, 27].
Previously proposed “virulence-associated” genes were
not systematically clustered on the basis of disease pheno-
type [28, 29] among these isolates. Within-cluster analysis
identified two genes that had alterations specific to the
four carried isolates of Cluster 1: NEIS1527 encodes a
two-component response regulator member of the ActR/
RegA family that is involved in signal transduction mech-
anism and transcription [30] and NEIS2894 encodes a
hypothetical protein of unknown function. The impact of
these genetic mutations in the biological function of these
bacteria would need to be assessed further.
The use of wgSNP analysis to detect nucleotide changes
in non-coding regions that discriminated carried and inva-
sive isolates identified 9.4% of SNPs in non-coding regions
(Additional file 2: Table S4). Only one SNP was found to
discriminate carried from invasive isolates of Cluster 1,
this SNP was found within the proximal promoter region
of the gene NEIS1545, which is known to include tran-
scription regulatory elements, but is located away from
the −10 and −35 region which are part of the core pro-
moter required for initiation of transcription [31]; add-
itional analyses is necessary to determine the impact of
this particular SNP on the transcription of NEIS1545.
The wgSNP Neighbor Net trees (Fig. 2b and Additional
file 1: Figure S4) showed identical phylogenetic clustering
to that found with the wgMLST tree (Fig. 2a), with the
same nodes; however, Cluster 1 appeared to be more di-
verse than observed with wgMLST analysis. SNPs found
in the non-coding regions specific to sub-clusters and sin-
gle isolates within Cluster 1 led to the observed diversity
(28 SNPs in total, Additional file 2: Table S4). The wgSNP
analysis based on the assembled fasta file and the original
fastq files gave similar results.
Gene presence does not always correlate with expres-
sion and it is possible that despite both disease and car-
riage isolates possessing the same complement of genes,
their expression levels might vary [32]. A study comparing
two serogroup B Nm (NmB) from different clonal com-
plexes, a carried ST-41/44 isolate and an invasive ST-32
isolate, identified eight putative virulence-associated genes
missing or non-functional from the carried isolate and
considerable differences in their expression patterns [33].
Nm are highly variable bacteria and it is difficult to deter-
mine whether changes are due to the different phenotype
or to inherent differences between the two clonal com-
plexes. Analyses with additional genomes from the same
clonal complexes are therefore essential for such compari-
sons. The results of the wgSNP analysis did not identify
any changes at the nucleotide sequence level that could
predict a change in gene expression between the carried
and invasive isolates of this study except for one SNP
found in the proximal promoter upstream of NEIS1545
that differentiated carried and invasive isolates of Cluster
1. A study applying similar methods to those presented
here compared 172 carried and invasive NmY collected in
the UK between 1997 and 2011 with an overlapping col-
lection of both phenotypes obtained only in 2010. As
found in this study, clusters of isolates contained both car-
ried and invasive isolates; however, these investigators
were able to identify a disease-associated clone within
their clonal complex 23 NmY, which included 90% of in-
vasive isolates [5].
The genetic differentiation between Clusters 1 and 2,
and their strong association with host age, may represent
bacterial adaptation to a particular niche and the change
in the ecology of the nasopharynx from children to young
adults in Chad. This is supported by the fact that most of
the allelic variations found between the clusters were
identified in metabolic genes (Tables 3 and 4). A previous
study of the pharyngeal carriage of members of the Neis-
seria genus found that there was an inverse relationship
between carriage of Nm and other non-pathogenic Neis-
seria species by age group which indicate a potential role
that other microbes may play in modulating Nm carriage
and could explain the age difference seen in this study
Table 5 Genes with alleles specific to the carried isolates of Cluster 1
Locus Functional category Number of mutation Number of non-synonymous mutation
NMAA_0123 Hypothetical protein Difference in G polymeric track length Preliminary stop Codona
NEIS1527 Two component response regulator Insertion of “GCGTT” Frameshift leading to a longer coding sequencea
NEIS2894 Hypothetical protein 1 (bp 65) 1 (T→ I)a
NEIS0291 (lot) LOS O-acetyltransferase 1 (bp 465) 0
aChange in the chemistry properties of the AA side chains
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[34]. Further studies, similar to those undertaken on the
gut microbiota [35, 36], might address this issue. DNA
microarray studies have identified a bacteriophage that
was mostly found in genomes from the hyper-invasive
clonal complexes [2]. This “meningococcal disease associ-
ated island” (MDA island) phage is associated with disease
in young adults [3]. The MDA island genes were present
in both Clusters 1 and 2 with the same alleles and thus
could not explain the differentiation seen in this collection
of isolates. Host genetic polymorphisms affecting the sus-
ceptibility of an individual to invasive meningococcal dis-
ease have been described, such as those in complement
components such as factor H [37] or C6 deficiencies
known to vary depending on the racial group and de-
scribed as more common in African-American in the
USA [38], interleukin-1 gene cluster [39] or the plasmino-
gen activator inhibitor 1 [40]. Differences in host genetics
could also explain our clusters; however, such studies have
yet to be undertaken in African subjects.
Conclusion
During the epidemic in and around N’Djamena, carriers
and cases were infected by meningococci that were indis-
tinguishable at the whole genome level, an observation
which is consistent with host factors playing a major role
in determining whether an infected person remains a car-
rier or becomes a case. Potential factors include the ability
of the host immune response to contain the meningococ-
cus in the pharynx or to eliminate it rapidly if invasion
does occur, an ability which is at least partly genetically
determined [37]. Gene expression among the isolates has
not been directly compared in this work, and this may also
play a role in the differentiation between carried and inva-
sive isolates; one interesting SNP was identified in this
study, upstream of a gene encoding a hypothetical protein,
both the SNP and function of the gene should be investi-
gated further to determine their role, if any, in meningo-
coccal colonization and disease. In addition, it is possible
that other bacteria within the pharyngeal microbiome in-
fluence the ability of a meningococcus to invade. Further
bacterial genetic and protein expression studies, micro-
biome and human genetic studies comparing carriers and
cases from similar backgrounds would help elucidate the
role played by each factor in isolation and understand
their interactions and the mechanisms driving Nm from a
carried commensal to an invasive pathogen.
Methods
Isolate collection
A total of 33 NmA carried isolates were collected during
the second MenAfriCar carriage survey in Chad in 2011
and stored in BHI and 20% glycerol in a −80 °C freezer.
These isolates were revived by inoculation on blood agar
plates (BAP) and incubated at 37 °C with 5% CO2 for
between 16 and 48 h. Ten viable isolates were recovered
and were included in this dataset.
CSF samples were collected from patients with meningi-
tis for laboratory confirmation as part of the national
meningitis surveillance program. The majority of menin-
gococci recovered from these specimens by culture
methods were stored at the meningitis reference labora-
tory in N’Djamena, Chad and a small number of isolates
were also stored at the WHO collaborating center for ref-
erence and research on Meningococci, based at the
Norwegian Institute of public Health. A total of 13 inva-
sive NmA were recovered and included in this analysis out
of the 98 reported in the 2011 surveillance records [14].
Ethical approval for the MenAfriCar studies were ob-
tained from the ethics committee of the London School
of Hygiene & Tropical Medicine and ethical committees
of each of the African partner institutions, with the ex-
ception of Chad, which did not have a formal ethical
committee at the time of this study. Here, approval was
granted by a committee that was established to oversee
the MenAfriCar studies by the Chad Ministry of Health.
Written informed consent or assent was obtained from
subjects who participated in the pharyngeal carriage
study. Invasive isolates from Chad were obtained from
CSF samples collected from patients during the course
of routine clinical care following a national protocol.
The MenAfriCar studies were registered with Clinical-
Trials.gov (NCT01119482).
DNA extraction and sequencing
DNA was extracted in two different laboratories: the
first batch included 19 isolates and DNA was extracted
using the DNeasy® Blood and Tissue kit (Qiagen) as pre-
viously described [24]. Briefly, a sterile 1 μl loop was
used to transfer bacterial growth into a tube containing
180 μl of buffer ATL and 20 μl of Proteinase K. The
tube was then incubated at 56 °C for at least 2 h with
intermittent mixing to lyse the cells. Following treatment
with RNase A and subsequent addition of buffer AL/
ethanol, the lysate was loaded on to the spinning column
provided and the DNA was extracted and purified
through a series of spinning and washing steps in
accordance with the manufacturer’s instructions employ-
ing two elution steps each using 75 μL of buffer AE. The
second batch included the remaining 4 isolates and
DNA was extracted using an Eppendorf robot and the
NucleoSpin 96 tissue kit (Macherey-Nagel) according to
manufacturer’s instructions.
DNA samples were sequenced at the Oxford Genomics
Centre. The library preparation was done using the Ultra
DNA Sample Prep Kit (NEBNext) according to the manu-
facturer instructions and automated using a Biomek FX
(Beckman Coulter). The genomic DNA (gDNA) was frag-
mented using the Episonic 2000 sonication system
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(Epigentek), then end-repaired, A-tailed and adapter-
ligated using adapter designed “in house” [41], before the
size selection, amplification and paired end sequencing
performed on the Illumina HiSeq 2000 using a 100 base
pair paired-end protocol as previously described [19].
Genome annotation
Short-read sequences were assembled using the Velvet
genome assembly program (v1.2.08) [42], after a per-
formance comparison with the program Spades (v3.9.1)
(Additional file 1: Table S3). All odd-numbered kmer
lengths between 21 and 99 were sampled using the
VelvetOptimiser software (v2.2.4) [43] to automatically
calculate the optimal assembly parameters for Velvet
(default optimization functions used). Assembled contigs
were deposited into the Neisseria PubMLST database
[21] which uses the Bacterial Isolate Genome Sequence
Database (BIGSdb) software [44]. Draft genomes were
first automatically curated at all loci defined in the data-
base using the BLAST algorithm [45] and a sequence
similarity threshold of >98%, allowing rapid annotation
of known alleles and sequences which were very similar
to defined loci [19]. Manual verification was then per-
formed for variable loci, such as those containing in-
ternal stop codons, frame shifts or those with sequence
similarities lower than 98%. Incomplete gene sequences
at the beginning or end of a contig were identified as
such and were excluded from further analyses.
Hierarchical genomic analysis
Hierarchical gene-by-gene analysis was performed: con-
ventional seven locus MLST [1], rMLST [46] and
wgMLST [19] using the BIGSdb Genome Comparator
tool [44] as previously described; briefly, the loci of
interest: (i) 7 housekeeping genes of MLST [1]; (ii) 53
ribosomal genes of rMLST [46]; and (iii) 2070 genes an-
notated in the WUE2594 reference genome for wgMLST
[47] were extracted from the 24 assembled genomes and
a pairwise allelic comparison was performed using Gen-
ome Comparator with the following parameters: Min %
identity of 70, Min % alignment of 50 and BLASTN
word size of 15. A total of 141 publically available NmA
from the ST-5 clonal complex (NmA:cc5), were obtained
from PubMLST.org/neisseria [21] and included in the
rMLST analysis to provide a global perspective to the
epidemic using Neighbor-Joining trees with 50 bootstrap
replications and the kimura 2-parameter model, gener-
ated with MEGA6 [48]. Only the unique strains were
represented and they were defined as groups of isolates
sharing the same alleles at all 53 ribosomal loci. The fin-
ished genome WUE2594 (GenBank accession number
FR774048), an NmA:cc5 invasive isolate [47], was used
as a reference genome for the wgMLST analysis.
Neighbor-Net trees were computed with SplitsTree
(version 4.13.1) [49] using distance matrices generated
by Genome Comparator after pairwise allelic compari-
sons of all 23 genomes at the loci of interest described
above. Isolates with allelic variations specific to each of
the clusters were identified from the variable gene lists
generated by Genome Comparator. The nucleotide
sequences of these genes were then extracted from
the database for each genome and aligned in MEGA6
[48]. All nucleotide sequences and amino acid
changes specific to a cluster were noted. The Artemis
Comparison Tool [50] and MAUVE [51] were used to
visualize, align and compare the organization of the
loci on the contiguous sequence assemblies (contigs)
obtained using default settings.
WgSNP analysis was performed using the program
kSNP3 [52] using first the velvet assembled fasta files,
then the raw fastq files of all 23 isolates alongside the fin-
ished reference genome WUE 2594. In order to use the
fastq files, first these were downloaded from the European
Nucleotide Archive (ENA) [53] using the ENA accession
numbers available in the PubMLST isolate records and
then processed with the tools from the FASTX-toolkit
[54], using the command-line : the low quality reads were
trimmed for each isolate data using “fastq_quality_trim-
mer” with a quality threshold of 28, then “fastq_to_fasta”
was used on the trimmed data to obtain fasta files for each
isolates (the –n option was used to keep all the sequences’
information available in the trimmed files). Once the fasta
files were obtained, the built in option “MakeKSNP3infile”
of kSNP3 was used to make the required input file,
“MakeFasta” was used to transform that “infile” into a
fasta format that was used to run “Kchooser” in order to
determine the optimal kmer size (k) or the length of the
sequence that kSNP3 will find in each isolate sequence
data; the optimal k was 19 for the velvet assembled fasta
files and 21 for the original fastq files. The values of k
obtained were then used to run kSNP3 with the annota-
tions from the reference genome WUE2594 manually
downloaded from genbank and including the gi numbers
(-genbank argument). Finally the output files were filtered
out to remove all the SNPs found in a coding region. The
Neighbor Net trees were computed using SplitsTree (ver-
sion 4.13.1) [49]. Further SNPs characterization was done
when necessary by visualizing the genome sequences in
Artemis and aligning the sequences of interest in MEGA6
[48], using MUSCLE [55].
Statistical analysis
The age, sex and geographical location of the meningo-
coccal cases and carriers were recovered. A t-test was
used to measure the statistical significance of the
changes in age distribution observed between Cluster 1
and 2 identified, by comparing the mean age of the indi-
viduals from which the isolates from each cluster were
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collected. A t-test was also used to measure significant
differences in the proportions of gender and prove-
nances between the clusters by comparing the propor-
tion of the gender group and the proportions of
different provenance of the individuals from which the
isolates came from between both clusters. T-tests were
performed in Excel (version 2013).
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